Forte Biosciences Balance Sheet Health
Financial Health criteria checks 6/6
Forte Biosciences has a total shareholder equity of $9.4M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $17.9M and $8.6M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$16.36m |
| Equity | US$9.37m |
| Total liabilities | US$8.58m |
| Total assets | US$17.95m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 37T's short term assets ($17.7M) exceed its short term liabilities ($8.6M).
Long Term Liabilities: 37T has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: 37T is debt free.
Reducing Debt: 37T has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 37T has sufficient cash runway for 7 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: 37T is forecast to have sufficient cash runway for 6 months based on free cash flow estimates, but has since raised additional capital.